167 related articles for article (PubMed ID: 30909853)
1. Developing small activating RNA as a therapeutic: current challenges and promises.
Kwok A; Raulf N; Habib N
Ther Deliv; 2019 Mar; 10(3):151-164. PubMed ID: 30909853
[TBL] [Abstract][Full Text] [Related]
2. Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma.
Setten RL; Lightfoot HL; Habib NA; Rossi JJ
Curr Pharm Biotechnol; 2018; 19(8):611-621. PubMed ID: 29886828
[TBL] [Abstract][Full Text] [Related]
3. Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer.
Voutila J; Reebye V; Roberts TC; Protopapa P; Andrikakou P; Blakey DC; Habib R; Huber H; Saetrom P; Rossi JJ; Habib NA
Mol Ther; 2017 Dec; 25(12):2705-2714. PubMed ID: 28882451
[TBL] [Abstract][Full Text] [Related]
4. RNA Activation-A Novel Approach to Therapeutically Upregulate Gene Transcription.
Tan CP; Sinigaglia L; Gomez V; Nicholls J; Habib NA
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770939
[TBL] [Abstract][Full Text] [Related]
5. Target-Recognition Mechanism and Specificity of RNA Activation.
Cao H; Meng X; Wang X; Liang Z
Adv Exp Med Biol; 2017; 983():41-51. PubMed ID: 28639190
[TBL] [Abstract][Full Text] [Related]
6. RNA-mediated gene activation.
Jiao AL; Slack FJ
Epigenetics; 2014 Jan; 9(1):27-36. PubMed ID: 24185374
[TBL] [Abstract][Full Text] [Related]
7. Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.
Reebye V; Huang KW; Lin V; Jarvis S; Cutilas P; Dorman S; Ciriello S; Andrikakou P; Voutila J; Saetrom P; Mintz PJ; Reccia I; Rossi JJ; Huber H; Habib R; Kostomitsopoulos N; Blakey DC; Habib NA
Oncogene; 2018 Jun; 37(24):3216-3228. PubMed ID: 29511346
[TBL] [Abstract][Full Text] [Related]
8. Small RNA-Guided Transcriptional Gene Activation (RNAa) in Mammalian Cells.
Li LC
Adv Exp Med Biol; 2017; 983():1-20. PubMed ID: 28639188
[TBL] [Abstract][Full Text] [Related]
9. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.
Ren S; Kang MR; Wang J; Huang V; Place RF; Sun Y; Li LC
Prostate; 2013 Oct; 73(14):1591-601. PubMed ID: 23836514
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Liver Cancer by C/EBPA saRNA.
Zhao X; Voutila J; Ghobrial S; Habib NA; Reebye V
Adv Exp Med Biol; 2017; 983():189-194. PubMed ID: 28639200
[TBL] [Abstract][Full Text] [Related]
11. saRNAdb: Resource of Small Activating RNAs for Up-regulating the Gene Expression.
Dar SA; Kumar M
J Mol Biol; 2018 Jul; 430(15):2212-2218. PubMed ID: 29625201
[TBL] [Abstract][Full Text] [Related]
12. Promoter-associated small double-stranded RNA interacts with heterogeneous nuclear ribonucleoprotein A2/B1 to induce transcriptional activation.
Hu J; Chen Z; Xia D; Wu J; Xu H; Ye ZQ
Biochem J; 2012 Nov; 447(3):407-16. PubMed ID: 23035981
[TBL] [Abstract][Full Text] [Related]
13. Small activating RNA binds to the genomic target site in a seed-region-dependent manner.
Meng X; Jiang Q; Chang N; Wang X; Liu C; Xiong J; Cao H; Liang Z
Nucleic Acids Res; 2016 Mar; 44(5):2274-82. PubMed ID: 26873922
[TBL] [Abstract][Full Text] [Related]
14. Defining features and exploring chemical modifications to manipulate RNAa activity.
Place RF; Noonan EJ; Földes-Papp Z; Li LC
Curr Pharm Biotechnol; 2010 Aug; 11(5):518-26. PubMed ID: 20662764
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Pancreatic Cancer by Aptamer Conjugated C/EBPα-saRNA.
Yoon S; Rossi JJ
Adv Exp Med Biol; 2017; 983():173-188. PubMed ID: 28639199
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice.
Zhou J; Li H; Xia X; Herrera A; Pollock N; Reebye V; Sodergren MH; Dorman S; Littman BH; Doogan D; Huang KW; Habib R; Blakey D; Habib NA; Rossi JJ
Mol Ther; 2019 May; 27(5):999-1016. PubMed ID: 30852139
[TBL] [Abstract][Full Text] [Related]
18. Tumor-selective lipopolyplex encapsulated small active RNA hampers colorectal cancer growth in vitro and in orthotopic murine.
Wang LL; Feng CL; Zheng WS; Huang S; Zhang WX; Wu HN; Zhan Y; Han YX; Wu S; Jiang JD
Biomaterials; 2017 Oct; 141():13-28. PubMed ID: 28666099
[TBL] [Abstract][Full Text] [Related]
19. saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription.
Portnoy V; Lin SH; Li KH; Burlingame A; Hu ZH; Li H; Li LC
Cell Res; 2016 Mar; 26(3):320-35. PubMed ID: 26902284
[TBL] [Abstract][Full Text] [Related]
20. Development of Therapeutic dsP21-322 for Cancer Treatment.
Kang MR; Li G; Pan T; Xing JC; Li LC
Adv Exp Med Biol; 2017; 983():217-229. PubMed ID: 28639203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
